Does ERTUGLIFLOZIN PIDOLATE Cause Product dose omission? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Product dose omission have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 4.0% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.
27
Reports of Product dose omission with ERTUGLIFLOZIN PIDOLATE
4.0%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission From ERTUGLIFLOZIN PIDOLATE?
Of the 27 reports.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?
Fungal infection (58)
Product dose omission issue (57)
Nausea (55)
No adverse event (53)
Urinary tract infection (52)
Diabetic ketoacidosis (34)
Dizziness (33)
Vomiting (31)
Blood glucose increased (30)
Drug ineffective (21)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Product dose omission Risk?
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN
ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI